-
公开(公告)号：US20210008537A1
公开(公告)日：2021-01-14
申请号：US16506419
申请日：2019-07-09
申请人： UOP LLC
摘要： A process for removing Hg2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with a titanium metallate ion exchanger to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchanger. The titanium metallate ion exchangers are represented by the following empirical formula: AmTiNbaSixOy. A composition is provided with the combination of the titanium metallate ion exchanger and bodily fluids or dialysis solutions. Also, provided is an apparatus comprising a matrix and the titanium metallate ion exchanger.
-
公开(公告)号：US10710892B2
公开(公告)日：2020-07-14
申请号：US16525253
申请日：2019-07-29
申请人： UOP LLC
发明人： Gregory John Lewis
IPC分类号： C01B39/54 , B01J29/85 , B01J29/87 , B01J29/80 , B01J20/18 , B01J29/84 , B01J37/00 , B01J37/04 , B01J37/10 , B01J20/04
摘要： A method of making and using a new family of crystalline microporous metalloalumino(gallo)phosphosilicate molecular sieves is disclosed. These molecular sieves have been synthesized and are designated high charge density (HCD) MeAPSOs. These metalloalumino(gallo)phosphosilicates are represented by the empirical formula of: Rp+rA+mM2+wExPSiyOz where A is an alkali metal such as potassium, R is at least one quaternary ammonium cation such as ethyltrimethylammonium, M is a divalent metal such as Zn and E is a trivalent framework element such as aluminum or gallium. This family of metalloalumino(gallo)phosphosilicate materials is stabilized by combinations of alkali and quaternary ammonium cations, enabling unique, high charge density compositions. The HCD MeAPSO family of materials have catalytic properties for carrying out various hydrocarbon conversion processes and separation properties for separating at least one component.
-
公开(公告)号：US11484875B2
公开(公告)日：2022-11-01
申请号：US16506419
申请日：2019-07-09
申请人： UOP LLC
摘要： A process for removing Hg2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with a titanium metallate ion exchanger to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchanger. The titanium metallate ion exchangers are represented by the following empirical formula: AmTiNbaSixOy. A composition is provided with the combination of the titanium metallate ion exchanger and bodily fluids or dialysis solutions. Also, provided is an apparatus comprising a matrix and the titanium metallate ion exchanger.
-
公开(公告)号：US20190382276A1
公开(公告)日：2019-12-19
申请号：US16525253
申请日：2019-07-29
申请人： UOP LLC
发明人： Gregory John Lewis
摘要： A method of making and using a new family of crystalline microporous metalloalumino(gallo)phosphosilicate molecular sieves is disclosed. These molecular sieves have been synthesized and are designated high charge density (HCD) MeAPSOs. These metalloalumino(gallo)phosphosilicates are represented by the empirical formula of: Rp+rA+mM2+wExPSiyOz where A is an alkali metal such as potassium, R is at least one quaternary ammonium cation such as ethyltrimethylammonium, M is a divalent metal such as Zn and E is a trivalent framework element such as aluminum or gallium. This family of metalloalumino(gallo)phosphosilicate materials is stabilized by combinations of alkali and quaternary ammonium cations, enabling unique, high charge density compositions. The HCD MeAPSO family of materials have catalytic properties for carrying out various hydrocarbon conversion processes and separation properties for separating at least one component.
-
公开(公告)号：US11964266B2
公开(公告)日：2024-04-23
申请号：US16506377
申请日：2019-07-09
申请人： UOP LLC
IPC分类号： B01J39/02 , A61M1/16 , A61M1/28 , A61M1/34 , A61M1/36 , B01D15/36 , B01D69/02 , B01D69/08 , B01J39/09 , B01J39/10 , B01J39/26 , B01J47/018 , B01J47/02 , B01J47/127 , A61K9/50
CPC分类号： B01J39/02 , A61M1/1696 , A61M1/287 , A61M1/3486 , A61M1/3679 , A61M1/3687 , B01D15/362 , B01D69/02 , B01D69/08 , B01J39/09 , B01J39/10 , B01J39/26 , B01J47/018 , B01J47/02 , B01J47/127 , A61K9/5042 , B01D2311/2626 , B01D2313/40 , B01D2325/12 , B01D2325/42
摘要： A process for removing Co2+, Pb2+, Cd2+ and Cr3+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchange composition to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchange composition. The ion exchange compositions are represented by the following empirical formula:
AmZraTibSncMdSixOy.
A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.-
6.发明申请公开(公告)号：US20210008267A1
公开(公告)日：2021-01-14
申请号：US16506465
申请日：2019-07-09
申请人： UOP LLC
摘要： A process for removing Sr2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchanger to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchanger. The ion exchangers are represented by the following empirical formula: AmZraTibSncMdSixOy. A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.
-
7.发明授权公开(公告)号：US11577014B2
公开(公告)日：2023-02-14
申请号：US16506465
申请日：2019-07-09
申请人： UOP LLC
IPC分类号： A61M1/16 , A61M1/28 , A61M1/36 , B01D15/36 , B01D69/02 , B01D69/08 , B01D69/10 , B01J39/02 , B01J39/09 , B01J39/10 , B01J47/12 , A61M1/34 , B01J47/127
摘要： A process for removing Sr2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchanger to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchanger. The ion exchangers are represented by the following empirical formula: AmZraTibSncMdSixOy. A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.
-
公开(公告)号：US20210008266A1
公开(公告)日：2021-01-14
申请号：US16506377
申请日：2019-07-09
申请人： UOP LLC
IPC分类号： A61M1/28 , B01D15/36 , B01D69/08 , B01D69/02 , B01J39/02 , B01J39/09 , B01J47/127 , B01J39/26 , B01J47/02 , B01J47/018
摘要： A process for removing Co2+, Pb2+, Cd2+ and Cr3+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchange composition to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchange composition. The ion exchange compositions are represented by the following empirical formula: AmZraTibSncMdSixOy. A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.014 秒)
